Role and regulation of prolyl hydroxylase domain proteins

被引:0
|
作者
G-H Fong
K Takeda
机构
[1] Center for Vascular Biology,Department of Cell Biology
[2] University of Connecticut Health Center,undefined
来源
Cell Death & Differentiation | 2008年 / 15卷
关键词
prolyl hydroxylases; hypoxia; angiogenesis; PHD2; EGLN1;
D O I
暂无
中图分类号
学科分类号
摘要
Oxygen-dependent hydroxylation of hypoxia-inducible factor (HIF)-α subunits by prolyl hydroxylase domain (PHD) proteins signals their polyubiquitination and proteasomal degradation, and plays a critical role in regulating HIF abundance and oxygen homeostasis. While oxygen concentration plays a major role in determining the efficiency of PHD-catalyzed hydroxylation reactions, many other environmental and intracellular factors also significantly modulate PHD activities. In addition, PHDs may also employ hydroxylase-independent mechanisms to modify HIF activity. Interestingly, while PHDs regulate HIF-α protein stability, PHD2 and PHD3 themselves are subject to feedback upregulation by HIFs. Functionally, different PHD isoforms may differentially contribute to specific pathophysiological processes, including angiogenesis, erythropoiesis, tumorigenesis, and cell growth, differentiation and survival. Because of diverse roles of PHDs in many different processes, loss of PHD expression or function triggers multi-faceted pathophysiological changes as has been shown in mice lacking different PHD isoforms. Future investigations are needed to explore in vivo specificity of PHDs over different HIF-α subunits and differential roles of PHD isoforms in different biological processes.
引用
收藏
页码:635 / 641
页数:6
相关论文
共 50 条
  • [11] 2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2
    Mecinovic, Jasmin
    Loenarz, Christoph
    Chowdhury, Rasheduzzaman
    Schofield, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6192 - 6195
  • [12] Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia
    Kurata, Yu
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [13] HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy?
    Gaete, Diana
    Rodriguez, Diego
    Watts, Deepika
    Sormendi, Sundary
    Chavakis, Triantafyllos
    Wielockx, Ben
    CANCERS, 2021, 13 (05) : 1 - 18
  • [14] Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson's Disease
    Rajagopalan, Subramanian
    Chinta, Shankar J.
    Andersen, Julie K.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (01) : 120 - 125
  • [15] Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice
    Li, Xiping
    Sutherland, Scott
    Takeda, Kotaro
    Fong, Guo-Hua
    Lee, Frank S.
    BLOOD CELLS MOLECULES AND DISEASES, 2010, 45 (01) : 9 - 19
  • [16] Prolyl hydroxylase domain inhibitors: can multiple mechanisms be an opportunity for ischemic stroke?
    Lanigan, Sinead M.
    O'Connor, John J.
    NEUROPHARMACOLOGY, 2019, 148 : 117 - 130
  • [17] HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
    Wenger, Roland H.
    Camenisch, Gieri
    Stiehl, Daniel P.
    Katschinski, Doerthe M.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (33) : 3886 - 3894
  • [18] Cloning of the Human MORG1 Promoter: Differential Regulation by Hypoxia and Prolyl-Hydroxylase Inhibitors
    Bondeva, Tzvetanka
    Wolf, Gunter
    GENES, 2022, 13 (03)
  • [19] Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification
    Negri, Armando Luis
    CLINICAL KIDNEY JOURNAL, 2023, 16 (02) : 205 - 209
  • [20] Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
    Holt-Martyn, James P.
    Chowdhury, Rasheduzzaman
    Tumber, Anthony
    Yeh, Tzu-Lan
    Abboud, Martine I.
    Lippl, Kerstin
    Lohans, Christopher T.
    Langley, Gareth W.
    Figg, William
    McDonough, Michael A.
    Pugh, Christopher W.
    Ratcliffe, Peter J.
    Schofield, Christopher J.
    CHEMMEDCHEM, 2020, 15 (03) : 270 - 273